Filter By Category
Archives
Share on -
ATLUPROFEN
Generic Name: ATLUPROFEN
ABSTRACT -
Atluprofen is documented here using the API name supplied. Public chemical records closely align this name with atliprofen-related thiophene-containing nonsteroidal anti-inflammatory drug research, including the S-atliprofen acid form with molecular formula C13H12O2S. The compound class is associated with cyclooxygenase inhibition and anti-inflammatory activity.
This document is for structured API information only. It is not a prescribing guide. Clinical use, if any, must follow the approved local label, trial protocol, and specialist medical supervision.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- No approved public dosing regimen is established for the supplied API name.
- If handled as an investigational NSAID-like compound, dosing must follow protocol-defined safety limits.
- Do not use as a substitute for approved analgesic or anti-inflammatory medicines.
SIDE EFFECTS-
Possible side effects and safety concerns include:
- Stomach pain, nausea, dyspepsia, diarrhea, or heartburn
- Dizziness, headache, rash, or fluid retention
- Gastrointestinal ulceration or bleeding is a class concern for NSAIDs
- Kidney function changes or blood pressure elevation may occur
- Allergic reactions including bronchospasm may occur in NSAID-sensitive patients.
ALLERGIC REACTIONS -
Hypersensitivity to Atluprofen or related compounds/products may occur. Symptoms may include:
- Immediate urticaria or generalized rash
- Facial, lip, tongue, or throat swelling
- Wheezing or breathing difficulty
- Dizziness, collapse, or anaphylaxis
Important: Patients who develop an allergic reaction to Atluprofen should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS-
Atluprofen may interact with certain medicines, protocols, vaccines, clinical conditions, or procedures. Caution is needed with:
- Anticoagulants, antiplatelets, corticosteroids, SSRIs, or other NSAIDs may increase bleeding risk.
- ACE inhibitors, ARBs, diuretics, lithium, or methotrexate may require monitoring.
- Alcohol can increase stomach bleeding risk.
- Use with investigational anti-inflammatory agents requires protocol review.
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Assess history of ulcer disease, kidney disease, cardiovascular disease, and NSAID allergy.
- Use caution in older adults and patients with hypertension or fluid retention.
- Avoid late-pregnancy exposure unless specifically directed by a clinician.
- Monitor for gastrointestinal bleeding and renal function in supervised studies.
WARNINGS –
- NSAID-like compounds can increase serious gastrointestinal and cardiovascular risks.
- Seek urgent care for chest pain, black stools, vomiting blood, or severe allergic symptoms.
- Do not combine with other NSAIDs unless directed by a clinician.
- Keep out of reach of children.
Share on -
. Developed by